StockData

Aspire-Lakewood vs Silo Pharma

ASBP and SILO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ASBP and SILO compare

Aspire-Lakewood is the larger company, worth 4.3 times as much as Silo Pharma ($11.6M against $2.7M).

Silo Pharma keeps more of each dollar of sales as profit, with a net margin of −8270% compared with −11314% at Aspire-Lakewood.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricASBPSILO
Size and price
Market cap$11.6M$2.7M
Share price$8.30$1.71
Change, 1 year95.8%−72.4%
Change, 5 years–−98.8%
Beta (5Y)–2.90
Employees–3
StockData Score
Total score22
Valuation score11
Growth score00
Performance score00
Health score11
Dividend score00
Valuation
P/S119×50.2× (better)
P/B1.0×0.6× (better)
Growth
Revenue growth (TTM)–−25.0%
Revenue growth, 5Y average–12.0%
Profitability
Gross margin−25.0%−14.8% (better)
Operating margin−7495% (better)−8250%
Net margin−11314%−8270% (better)
Return on equity−1032%−91.2% (better)
Financial health
Interest coverage−0.8× (better)−112.0×
Current ratio7.99 (better)5.36
Altman Z-score−0.10 (better)−5.17
Piotroski F-score34 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions–9.0%
Held by insiders1.4%13.8%
Insider net buying, 12 months–$2.1K
Short interest, % of float–1.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.